Federal Register / Vol. 65, No. 74 / Monday, April 17, 2000 / Notices 20477

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5212,

MSC 7850, Bethesda, MD 20892, (301) 435–

1251, bannerc@drg.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 26, 2000.

Time: 1:00 PM to 3:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Ranga V. Srinivas, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5108,

MSC 7852, Bethesda, MD 20892, (301) 435–

1167, srinivar@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 26, 2000.

Time: 1:00 to 3:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Jean Hickman, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4194,

MSC 7808, Bethesda, MD 20892, (301) 435–

1146.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 26, 2000.

Time: 2:00 to 4:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Syed Husain, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5216,

MSC 7850, Bethesda, MD 20892–7850, (301)

435–1224.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 26, 2000.

Time: 2:00 to 3:00 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Alexander D. Politis, PhD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4204,

MSC 7812, Bethesda, MD 20892, (301) 435–

1225, politisa@csr.nih.gov.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 27, 2000.

Time: 8 AM to 9 AM.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Residence Inn By Marriott, Pentagon

City, 550 Army Navy Drive, Arlington, VA

22202.

Contact Person: Philip Perkins, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4148,

MSC 7804, Bethesda, MD 20892, (301) 435–

1718.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 27–28, 2000.

Time: 9 AM to 5 PM.

Agenda: To review and evaluate grant

applications and/or proposals.

Place: Residence Inn By Marriott, Pentagon

City, 550 Army Navy Drive, Arlington, VA

22202.

Contact Person: Philip Perkins, PHD,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4148,

MSC 7804, Bethesda, MD 20892, (301) 435–

1718.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 27, 2000.

Time: 1 PM to 4 PM.

Agenda: To review and evaluate grant

applications.

NIH, Rockledge 2, Bethesda, MD 20892,

(Telephone Conference Call).

Contact Person: H. Mac Stiles, MPH,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 4108,

MSC 7816, Bethesda, MD 20892, 301–435–

1785.

This notice is being published less than 15

days prior tot he meeting due to the timing

limitations imposed by the review and

funding cycle.

Name of Committee: Center for Scientific

Review Special Emphasis Panel.

Date: April 27, 2000.

Time: 1 PM to 2 PM.

Agenda: To review and evaluate grant

applications.

Place: NIH, Rockledge 2, Bethesda, MD

20892, (Telephone Conference Call).

Contact Person: Mary Clare Walker,

Scientific Review Administrator, Center for

Scientific Review, National Institutes of

Health, 6701 Rockledge Drive, Room 5104,

MSC 7852, Bethesda, MD 20892, (301) 435–

1165.

This notice is being published less than 15

days prior tot he meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.306, Comparative Medicine,

93.306; 93.333, Clinical Research, 93.333,

93.337, 93.393–93.396, 93.837–93.844,

93.846–93.878, 93.892, 93.893, National

Institutes of Health, HHS)

Dated: April 7, 2000.

Anna Snouffer,

Acting Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 00–9441 Filed 4–14–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Statement of Organization, Functions,

and Delegations of Authority

Part N, National Institutes of Health,

of the Statement of Organization,

Functions, and Delegations of Authority

for the Department of Health and

Human Services (40 FR 22859, May 27,

1975, as amended most recently at 64

FR 49018, September 9, 1999, and

redesignated from Part NH as Part N at

60 FR 56606, November 9, 1995), is

amended as set forth below to reflect the

establishment of the Office of

Bioengineering and Bioimaging in the

Office of the Director, National

Institutes of Health.

Section N–B, Organization and

Functions, is amended as follows: (1)

After the heading Executive Office

(NAR, formerly HNAR), insert the

following:

Office of Bioengineering and

Bioimaging (NAC, formerly HNAC). (1)

Increases biological knowledge and

facilities development of novel

methods, devices, and pharmaceuticals

through the use of engineering,

physical, and computational science

principles and techniques; (2)

coordinates and provides a focus for

biomedical engineering, bioimaging,

and bioinformatics issues among the

institutes and centers at the NIH and

with other Federal agencies; (3)

conducts activities aimed at fostering

new basic understandings and

collaborations among the biological,

medical, engineering, physical, and

computational sciences; (4) coordinates

trans-NIH bioengineering, bioimaging,

and bioinformatics research programs;

(5) develops transdisciplinary training

and career development opportunities

between the engineering/physical/

computational science and biomedical

communities; and (6) conducts

symposia and technical meetings to

facilitate communication and

20478 Federal Register / Vol. 65, No. 74 / Monday, April 17, 2000 / Notices

dissemination of information among

different technical disciplines.

Dated: April 5, 2000.

Ruth Kirschstein,

Acting Director, National Institutes of Health.

[FR Doc. 00–9431 Filed 4–14–00; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Public Health Service

National Institute of Environmental

Health Sciences, NIH; National

Toxicology Program; Peer Review

Meeting on Low-Dose Issues for

Endocrine Disruptors; Scope of

Information Considered for Review

Broadened, Deadline for Receipt of

Information Extended, and Date for

Meeting Delayed

Summary

The National Toxicology Program

(NTP) is organizing a Peer Review to

evaluate whether chemicals can cause

hormone-related effects at doses lower

than those typically used in the

standard toxicological dose-setting

paradigm. The U.S. Environmental

Protection Agency (EPA) Endocrine

Disruptor Screening Program will use

the results from this peer review to

assist in determining how to identify

and characterize potential low-dose

effects that may arise during endocrine

disruptor screening, testing, and hazard

assessment.

On January 6, 2000 the NTP

published a Federal Register notice

[Volume 65, Number 4, pages 784–787]

outlining plans for the Peer Review

meeting and soliciting public input into

the process. This notice broadens the

request for research studies and data to

be considered and extends previously

announced deadlines for receipt for

research information for use in this peer

review.

Broader Request for Research Studies

to be Considered for the Peer Review

On January 6, 2000, the NTP

published a Federal Register notice

[Volume 65, Number 4, pages 784–787]

providing details about a Peer Review

meeting to evaluate scientific data on

the potential low-dose effects associated

with exposure to endocrine disruptors.

In that notice, the NTP solicited

comments on the planned scope and

process of the proposed peer review,

nominations of studies for inclusion in

this review, as well as nominations of

individuals for the Peer Review panel.

The notice also detailed the criteria for

selection of studies for review.

The NTP Selection/Organizing

Committee will review the nominated

studies and designate them as either

critical to resolution of the low-dose

issue or background information. The

January 6th notice stipulated that

studies nominated for consideration in

this peer review should have been

published or accepted for publication by

April 1, 2000. The NTP is now

broadening the scope of studies to be

considered for this peer review to

include relevant data from unpublished

studies. Submission of unpublished

studies should include an abstract of the

study describing the hypothesis being

tested, experimental design [model

system (cell line, species, strain, number

per group, etc.), dosing regimen,

duration of treatment and follow-up],

endpoints evaluated, and results (if

available).

If an unpublished study is nominated

for consideration, the NTP will contact

the principal investigator for an update

of the study’s status and to obtain

additional information about the study.

If selected by the NTP Selection/

Organizing Committee, the studies will

be distributed to the Peer Review panel

for its review and evaluation. The NTP

may need access to raw data for

subsequent independent analysis by the

Panel. As with published studies and

studies accepted for publication but not

yet published, all information given to

the Peer Review Panel will

simultaneously be made available to the

public. Therefore, studies, which are

unpublished by the date of their

distribution to the Panel, will require

approval from the author (and publisher

if accepted for publication) in order to

be included in the Peer Review. A list

of the studies included in the Peer

Review will be posted on the NTP web

page (http://ntp-server.niehs.nih.gov)

and available from NTP Liaison and

Scientific Review Office (NIEHS/NTP,

P.O. Box 12233, Research Triangle Park,

NC 27709; t: 919–541–0530; f: 919–541–

0295). Federal Register announcement.

Planning for the Peer Review Meeting is

ongoing and the date and location will

be announced in the Federal Register in

the near future.

Solicitation of Public Comment

Comments about the scope and

process for the Peer Review are

welcome. The deadline for submission

of comments, identified by docket

control number OPPTS–42208A, is

extended from February 22, 2000 to May

22, 2000.

Guidelines for Submission of Public

Comment

The EPA will manage the recordkeeping aspects of the Peer Review as

part of the Endocrine Disruptor

Screening Program. General information

about the U.S. EPA Endocrine Disruptor

Screening Program is available from the

Internet at http://www.epa.gov/scipoly/

oscpendo/index.htm or by contacting

Mr. James Kariya (contact information

provided below).

The EPA has established an official

record for this action under docket

control number OPPTS–42208A. The

official record consists of the document

specifically referenced in this action,

any public comments received during

an applicable comment period, and

other information related to this action.

This official record includes the

documents that are physically located in

the docket, as well as the documents

that are referenced in those documents.

The public version of the official record

does not include any information

claimed as confidential business

information (CBI). The public version of

the official record, which includes

printed, paper versions of any electronic

comments submitted during an

applicable comment period, is available

for inspection in the TSCA

Nonconfidential Information Center,

North East Mall Room B–607, Waterside

Mall, 401 M. Street, SW, Washington,

DC. The Center is open from noon to 4

PM., Monday through Friday, excluding

legal holidays. The telephone number of

the Center is (202) 260–7099.

Comments can be submitted through

the mail, in person, or electronically. To

ensure proper receipt by EPA, it is

imperative that the docket control

number OPPTS–42208A is identified in

the subject line on the first page of the

comments.

1. By mail: Submit comments to:

Document Control Office (7407), Office

of Pollution Prevention and Toxics

(OPPT), Environmental Protection

Agency, 1200 Pennsylvania Avenue

NW, Washington, DC 20460.

2. In person or by courier: Deliver

comments to: OPPT Document Control

Office (DCO) in East Tower Rm. G–099,

Waterside Mall, 401 M St. SW,

Washington, DC. The DCO is open from

8 a.m. to 4 p.m., Monday through

Friday, excluding legal holidays. The

telephone number for the DCO is (202)

260–7093.

3. Electronically: Submit comments

electronically by e-mail to:

‘‘oppt.ncic@epa.gov,’’ or mail the

computer disk to the Document Control

Office (address identified above). The

form must be identified by docket